Attenuation of Equine Influenza Viruses through Truncations of the NS1 Protein

Abstract

Equine influenza is a common disease of the horse, causing significant morbidity worldwide. Here we describe the establishment of a plasmid-based reverse genetics system for equine influenza virus. Utilizing this system, we generated three mutant viruses encoding carboxy-terminally truncated NS1 proteins. We have previously shown that a recombinant human influenza virus lacking the NS1 gene (delNS1) could only replicate in interferon (IFN)-incompetent systems, suggesting that the NS1 protein is responsible for IFN antagonist activity. Contrary to previous findings with human influenza virus, we found that in the case of equine influenza virus, the length of the NS1 protein did not correlate with the level of attenuation of that virus. With equine influenza virus, the mutant virus with the shortest NS1 protein turned out to be the least attenuated. We speculate that the basis for attenuation of the equine NS1 mutant viruses generated is related to their level of NS1 protein expression. Our findings show that the recombinant mutant viruses are impaired in their ability to inhibit IFN production in vitro and they do not replicate as efficiently as the parental recombinant strain in embryonated hen eggs, in MDCK cells, or in vivo in a mouse model. Therefore, these attenuated mutant NS1 viruses may have potential as candidates for a live equine influenza vaccine.

Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing

“…Templates for T7 RNA transcription were synthesized from PR8 pDZ plasmids coding for individual RNA segments of influenza PR8 virus (30). T7 SeV-C DI particle template was created by RT amplification of SeV DI RNA from infected cells.…”

Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses

“…Briefly, different components of the cHA were amplified by PCR with primers containing Sap I sites, digested with Sap I, and cloned into the Sap I sites of the pDZ plasmid (34). For generation of the baculotransfer plasmids, cH6/1 and cH9/1 were amplified by PCR, cut with BamHI and NotI, and cloned in frame into a modified pFastBac (Invitrogen) baculotransfer vector that harbors a C-terminal T4 phage fold-on and a 6-his tag (35).…”

Rewiring the RNAs of influenza virus to prevent reassortment

“…The 1.2-kb KpnI fragment from the previously constructed pDZ-NS plasmid (19) was transferred to the KpnI site of pUC18 vector and subjected to sitedirected mutagenesis to mutate two ATGs (A27T, A76T), one splice site (G57C), and to generate one NheI site (A104G, G109C) and one XhoI site (G759C, A760G). The 1.2-kb NS KpnI fragment was then transferred back to the pDZ vector (19) (in which the NheI and XhoI sites have been removed), resulting in a plasmid pDZ-NS-ps. The ORF of the A/PR/8/34 HA protein, which is 1,698 bp long, was amplified from an ambisense pDZ-HA plasmid (19) and subjected to mutagenesis to mutate an internal XhoI site (C143G).…”

“…The 1.2-kb NS KpnI fragment was then transferred back to the pDZ vector (19) (in which the NheI and XhoI sites have been removed), resulting in a plasmid pDZ-NS-ps. The ORF of the A/PR/8/34 HA protein, which is 1,698 bp long, was amplified from an ambisense pDZ-HA plasmid (19) and subjected to mutagenesis to mutate an internal XhoI site (C143G). Two restriction sites, NheI and XhoI, were introduced to flank the HA ORF, which was then used to replace the NheI and XhoI fragment of the NS ORF of pDZ-NS-ps plasmid to form the NS-HAwt-NS construct (Fig.…”

“…The method for generating recombinant influenza viruses was slightly modified from previous protocols (15,19,20). For the generation of the Swap(wt) and Swap(mut) viruses (Figs.…”